The Food and Drug Administration (FDA) issued a public warning on Thursday, June 11, 2026, regarding an unregistered drug product circulating in the market. In its Advisory No. 2026-0622, the FDA specifically cautioned against the use of "Pepslim Bacteriostatic Water 3mL Vial."
Unregistered Product Identified
Through its Post-Marketing Surveillance (PMS) activities, the FDA confirmed that the product has not undergone the mandatory registration process. Consequently, it has not been issued a Certificate of Product Registration (CPR), which is a legal requirement for all drug products sold in the country.
Health Risks Highlighted
The FDA stressed that the public cannot be assured of the product's quality, safety, and efficacy. "Consumers are strongly warned that the use or consumption of this violative product may expose them to potential health risks, including possible injury or harm," the agency stated. It advised the public against purchasing or using the unregistered drug product.
Distribution Prohibited
The FDA also warned all concerned establishments and entities not to distribute the said product. Furthermore, it called upon local government units and law enforcement agencies to ensure that the product is not sold or made available within their jurisdictions.
The advisory underscores the FDA's commitment to protecting public health by monitoring and regulating drug products in the market. Consumers are urged to report any sightings of the product to the FDA.
